<SEC-DOCUMENT>0001127602-16-043390.txt : 20160225
<SEC-HEADER>0001127602-16-043390.hdr.sgml : 20160225
<ACCEPTANCE-DATETIME>20160225182803
ACCESSION NUMBER:		0001127602-16-043390
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20160223
FILED AS OF DATE:		20160225
DATE AS OF CHANGE:		20160225

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INSULET CORP
		CENTRAL INDEX KEY:			0001145197
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				043523891
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		600 TECHNOLOGY PARK
		STREET 2:		SUITE 200
		CITY:			BILLERICA
		STATE:			MA
		ZIP:			01821
		BUSINESS PHONE:		978-600-7000

	MAIL ADDRESS:	
		STREET 1:		600 TECHNOLOGY PARK
		STREET 2:		SUITE 200
		CITY:			BILLERICA
		STATE:			MA
		ZIP:			01821

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			LEVANGIE DANIEL J
		CENTRAL INDEX KEY:			0001187406

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33462
		FILM NUMBER:		161457341

	MAIL ADDRESS:	
		STREET 1:		85 SWANSON ROAD
		CITY:			BOXBOROUGH
		STATE:			MA
		ZIP:			01719
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0306</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2016-02-23</periodOfReport>

    <issuer>
        <issuerCik>0001145197</issuerCik>
        <issuerName>INSULET CORP</issuerName>
        <issuerTradingSymbol>PODD</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001187406</rptOwnerCik>
            <rptOwnerName>LEVANGIE DANIEL J</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O INSULET CORPORATION</rptOwnerStreet1>
            <rptOwnerStreet2>600 TECHNOLOGY PARK DRIVE, SUITE 200</rptOwnerStreet2>
            <rptOwnerCity>BILLERICA</rptOwnerCity>
            <rptOwnerState>MA</rptOwnerState>
            <rptOwnerZipCode>01821</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isOfficer>1</isOfficer>
            <officerTitle>President, Drug Delivery</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2016-02-23</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness></transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>6813</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>17476</value>
                    <footnoteId id="F1"/>
                    <footnoteId id="F2"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">The 6,813 performance share units were granted on April 1, 2015, and the Compensation Committee of the Board of Directors determined on February 23, 2016 that the performance share units were earned based on the performance of the Company.  The full award remains subject to time-based vesting in accordance with the following schedule: one-third of the performance share units vest on April 1, 2016, one-third of the performance share units vest on April 1, 2017 and one-third of the performance share units vest on April 1, 2018.  Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.</footnote>
        <footnote id="F2">Includes 1,000 restricted stock units granted on June 3, 2013 which vest on April 30, 2016; and 2,000 restricted stock units granted on June 2, 2014, which vest 50% of the total units on April 30, 2016 and 50% of the total units on April 30, 2017, subject to continued service as a director or consultant.  Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ David Colleran, attorney-in-fact</signatureName>
        <signatureDate>2016-02-25</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
